Navigation Links
Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients
Date:8/4/2008

ned Virologic Response (ITT)*

Treatment Arm All patients

No P/R Lead-in 28 Weeks 55% (59/107)

P/R Lead-in 28 Weeks 56% (58/103)

No P/R Lead-in 48 Weeks 66% (68/103)

P/R Lead-in 48 Weeks 74% (76/103)

P/R Control 48 Weeks 38% (39/104)

P/R Lead-in equals PEGINTRON and REBETOL for 4 weeks prior to the addition of boceprevir

P/R Control equals PEGINTRON and REBETOL alone for 48 weeks

* SVR 12 for 48 week arms; SVR 24 for 28 week arms(1-3)

"These top-line results further validate this novel treatment paradigm and the design of our pivotal Phase III studies of boceprevir, one in treatment-naive patients and one in patients who had failed prior treatment, in which all patients will receive 4 weeks of PEGINTRON and REBETOL prior to the addition of boceprevir," said Thomas P. Koestler, Ph.D., executive vice president and president of Schering-Plough Research Institute. "Additionally, this strategy has the potential to reduce the likelihood of the development of resistance by identifying patients who are responders to interferon and ribavirin prior to their receiving a protease inhibitor."

The rationale for this novel treatment regimen is based on the fact that both PEGINTRON and REBETOL reach steady-state concentrations by week 4, so patients have the protease inhibitor added at a time when the backbone drug levels have been optimized. In addition, the patient's immune system will have been activated and primed by PEGINTRON at the time that boceprevir is added to the regimen. This approach may minimize the period of time when there is a "functional monotherapy" with a direct antiviral, potentially reducing the likelihood for the development of resistance.

The HCV SPRINT-1 study was conducted at sites across the United States, Canada and Europe. Overall, 77
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Genmab and GlaxoSmithKline Announce Positive Top-Line Results in Ofatumumab Chronic Lymphocytic Leukemia Pivotal Study
2. NicOx Announces Top-Line Results From Naproxcinod 52-Week 301 Safety Extension
3. Medivation Announces Positive Top-Line Results From Phase 2 Dimebon Study in Huntingtons Disease
4. Medivation to Host Conference Call at 5 p.m. EDT Monday to Discuss Top-Line Phase 2 Study Results in Huntingtons Disease
5. Inspires Phase 3 CF Trial, Using PARIs Nebulizer & Compressor, Shows Positive Top-Line Results
6. Cardica Reports Positive Top-Line Results and Submits 510(k) for PAS-Port(R) Proximal Anastomosis System in Cardiac Bypass Surgery
7. Statement From the Lupus Foundation of America Regarding the Release of Top-Line Results From a Study of Rituxan for the Treatment of Lupus
8. InterMune Announces Top-Line Results of Phase 1b Trial of ITMN-191 (R7227) and Provides Program Update
9. Schering-Plough Reports Top-Line Results of the IDEAL Study
10. Exelixis Reports Top-Line Results of the Phase 2 Trial of XL784 in Patients With Proteinuria Associated With Diabetic Nephropathy
11. Top-Line Efficacy Data Presented from Phase 2 Trial of Alemtuzumab in Multiple Sclerosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... BOCA RATON, Fla. , Sept. 2, 2015 ... Cartledge , MD, FACS, has begun performing ultra-minimally ... patients who are on anticoagulants such as Coumadin, ... of Cardiothoracic Surgery at the Hospital, is one ... this method, which involves making two microscopic incisions ...
(Date:9/2/2015)... 2, 2015  Aethlon Medical, Inc. (Nasdaq: AEMD ), ... will be presenting at the Rodman & Renshaw 17th Annual ... at 9:35 a.m. ET on Thursday, September 10, 2015. ... public via live audio webcast which can be accessed by ... at http://www.aethlonmedical.com . The webcast will be archived for ...
(Date:9/2/2015)... TORONTO , Sept. 2, 2015 ... (OTCQB: GNBT) today announced that its previously ... co-development arrangement with CannScience Innovations Inc. ( ... Generex and CannScience have entered into a ... to the Agreement, Generex has licensed its ...
Breaking Medicine Technology:Boca Regional Introduces Ultra-Minimally Invasive Surgical Procedure for Atrial Fibrillation Patients 2Boca Regional Introduces Ultra-Minimally Invasive Surgical Procedure for Atrial Fibrillation Patients 3Generex Announces Formalization of Buccal Cannabis Co-Development Plan 2Generex Announces Formalization of Buccal Cannabis Co-Development Plan 3
(Date:9/2/2015)... ... 2015 , ... The medical waste management market is expected to reach USD ... 5.2%. The global medical waste management market is segmented based on type of waste, ... to register the highest growth rate in the medical waste management market, by service, ...
(Date:9/2/2015)... ... September 02, 2015 , ... Michael Elliot Media announces a crowdfunding ... actress as the primary love interest in the film. The campaign is being called ... affects how and what we think,” Michael Elliot, an award-winning screenwriter and CEO of ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... food banks in commemorating “Hunger Action Month” during the entire month of September. ... Food Bank will be dedicating its efforts this September to an awareness campaign ...
(Date:9/2/2015)... ... September 02, 2015 , ... Since 2011, DoMyOwnPestControl.com ... Atlanta to help support childhood cancer research. On June 17, 2014, the ... Care-A-Thon , which is the fund-raising event DoMyOwnPestControl.com sponsors each year. The very ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... companies, has completed a recapitalization with new investment partners Beecken Petty O’Keefe ... Group each offer extensive expertise and connections within the healthcare industry, which ...
Breaking Medicine News(10 mins):Health News:Medical Waste Management Market Growing at 5.2% CAGR to 2020 2Health News:Medical Waste Management Market Growing at 5.2% CAGR to 2020 3Health News:Medical Waste Management Market Growing at 5.2% CAGR to 2020 4Health News:Medical Waste Management Market Growing at 5.2% CAGR to 2020 5Health News:Award-Winning Screenwriter Uses Crowdfunding Campaign to Change Hollywood’s Ideal of Beauty to Include PLUS-SIZE Women 2Health News:#IfOnlyYouKnew: Alameda County Community Food Bank Commemorates September as National Hunger Action Month 2Health News:#IfOnlyYouKnew: Alameda County Community Food Bank Commemorates September as National Hunger Action Month 3Health News:#IfOnlyYouKnew: Alameda County Community Food Bank Commemorates September as National Hunger Action Month 4Health News:DoMyOwnPestControl.com Goes Gold for Childhood Cancer Awareness Month 2Health News:Medical Solutions Completes Recapitalization with Beecken Petty O’Keefe & Company and Heritage Group 2Health News:Medical Solutions Completes Recapitalization with Beecken Petty O’Keefe & Company and Heritage Group 3Health News:Medical Solutions Completes Recapitalization with Beecken Petty O’Keefe & Company and Heritage Group 4
... North America -, PRINCETON, N.J., Dec. 18 ... Barr has been named Covance,s Chief,Operating Officer, effective ... of Early Development North America, will assume operating,responsibility ... to,Joe Herring, Covance,s Chairman and Chief Executive Officer. ...
... slightly more effective than traditional lung scans, , , TUESDAY, ... a life-threatening blood clot in the lungs -- can ... a technique using CT scanning might be slightly more ... Canadian researchers found that computed tomographic pulmonary angiography (CTPA) ...
... team of researchers led by Mayo Clinic have designed a ... to destroy cancer cells that spread from primary tumors to ... addition, their study shows that this technology could be the ... , The study appeared in the Dec. 9 online issue ...
... screenings for those with severe illnesses, they may bring ... a recent study by Yale School of Medicine researchers ... study offers a new approach for assessing who is ... recommendations can be tailored more effectively to individual patients. ...
... NightHawk,Radiology Holdings, Inc. (Nasdaq: NHWK ), ... and hospitals throughout the United States,today announced that ... Healthcare,Conference, January 10, 2008, at 8:30 a.m. PST ... Paul Berger, Chairman and CEO, Tim Mayleben, President,and ...
... Dec. 18 Psoriasis Cure Now,a nonprofit patient ... an association between severe psoriasis and a significantly,increased ... psoriasis research. The,study, by a team of University ... severe psoriasis have a 50 percent,increased risk of ...
Cached Medicine News:Health News:Wendel Barr Appointed Chief Operating Officer of Covance 2Health News:Wendel Barr Appointed Chief Operating Officer of Covance 3Health News:CT Scans Catch More Clots in Lungs 2Health News:CT Scans Catch More Clots in Lungs 3Health News:Researchers train the immune system to deliver virus that destroys cancer in lab models 2Health News:Researchers train the immune system to deliver virus that destroys cancer in lab models 3Health News:Colon cancer screenings may not pay off and could pose harm to some 2Health News:NightHawk Radiology Holdings, Inc. to Speak at Annual JPMorgan Healthcare Conference on January 10, 2008 2
Histopathology Reference Laboratory provides a full range of histology services, encompassing routine and specialized grossing, processing, embedding, microtomy, routine and special staining and cove...
IBT Reference Laboratory is a national research and specialty clinical lab founded in 1983 that provides a wide range of tests and services in the area of allergy, clinical immunology and molecular b...
Marquette General Health System Reference Laboratory provides a full range of testing including, Chemistry, Hematology, Coagulation, Urinalysis, Microbiology, Cytology, Anatomic Pathology, Flow Cytom...
Headquartered in Burlington, North Carolina, LabCorp has more than 23,500 employees and offers more than 4,400 clinical tests ranging from routine blood analyses to the most sophisticated molecular d...
Medicine Products: